With regards to EZH2 inhibition, low concentrations of GSK126 enhance the growth of some colorectal cancer organoids (48), an effect we confirm in a subset of the organoids in this dataset (Supplementary Fig. S5). The gene discussed is EZH2; the disease is colorectal cancer.